期刊文献+

特比萘芬对24株黑酵母样真菌的体外药敏试验研究 被引量:1

In vitro antifungal susceptibility of terbinafine against 24 strains of black yeast like fungi
下载PDF
导出
摘要 目的 评价特比萘芬对7个属24株刺盾霉目(Chaetothyriales)黑酵母样真菌体外敏感性.方法 应用美国国家临床和实验室标准研究所(CLSI)的M38-A2方案.菌悬液终浓度为(0.4 ~5)×104 CFU/mL,30℃孵育5~7d,测定最低有效浓度(MEC)和最低抑菌浓度(MIC).结果 特比萘芬对24株黑酵母样真菌MEC范围:0.125 ~4μg/mL,MEC90∶2μg/mL,MEC50∶0.25 μg/mL,GM∶0.392 9 μg/mL,特比萘芬对5株暗色真菌100%生长抑制,MIC范围:1~4 μg/mL,MIC50∶2μg/mL,MIC90∶4μg/mL.结论 特比萘芬对刺盾霉目(Chaetothyriales)中的黑酵母样真菌有较强的抑制作用,50%抑菌作用明显. Objective To investigate the in vitro susceptibility testing of terbinafine against 24 strains of Black yeast like fungi. Methods CLSI M38-A2 guideline was applied. The media containing the fungi in the concentration of O. 5 ×10^4-4×10^4 CFU/mL were incubated at 30 for 5-7 days. The MIC and MEC values were observed. Results The tested 24 strain of black yeast like fungi were susceptible to terbinafine, MEC range :0. 125 Ixg/mL-4 txg/mL, MECgo :2μg/mL, MEC5o :0.25μg/mL, GM :0. 392 9μg/mL, Five strains had 100% growth inhibition,MIC range:l-4 μg/mL, MIC5o :2μg/mL;MICgo :4 μg/mL. Conclusion Terbinafine is ac- tive aganist black yeast like fungi in order Chaetothyriales. Most strains had MEC which 50% growth inhibition by terbinafine.
出处 《中国真菌学杂志》 CSCD 2014年第4期218-221,共4页 Chinese Journal of Mycology
基金 国家973项目(2013CB531601 2013CB531606) 国家科技重大传染病专项(2013ZX10004612-001) 云南省联合专项重点项目(2012FB006) 上海市科委专项(14DZ2272900 12JC141000)
关键词 黑酵母样真菌 药敏试验 特比萘芬 black yeast antifungal susceptibility tests terbinafine
  • 相关文献

参考文献10

  • 1de Hoog GS,Guarro J,Gené J,et al.Atlas of Clinical Fungi[M].2nd ed.Centraalbureau voor Schimmelcultures,Utrecht,The Netherlands and Universitat Rovira i Virgili,Reus,Spain,2000.
  • 2Clinical and Laboratory Standards Institute.Reference method for broth dilution antifungal susceptibility testing of filamentous fungi,2nd ed.Approved standard.CLSI documentM38-A2[S].Clinical and Laboratory Standards Institute,Wayne,PA,2008.
  • 3Deng S,van den Ende AH,Ram AF,et al.Evolution of CDC42,a putative virulence factor triggering meristematic growth in black yeasts[J].Stud Mycol,2008,61:121-129.
  • 4Li RY,Wang DL.Studies on phaeohyphomycosis and its causative agents in China[J].Jap J Med Mycol,1996,37 (3):135-141.
  • 5Li DM,de Hoog GS.Cerebral phaeohyphomycosis-a cure at what lengths[J]? Lancet Infect Dis,2009,9 (6):376-383.
  • 6Kanj SS,Amr SS,Roberts GD.Ramichloridium mackenziei,brain abscess:report of two cases and review of the literature[J].Med Mycol,2001,39(1):97-102.
  • 7张敏,万喆,余进,李若瑜.特比萘芬和伊曲康唑联合应用对暗色孢科真菌的体外药敏试验研究[J].中国真菌学杂志,2007,2(2):78-80. 被引量:5
  • 8Deng S,de Hoog GS,Badali H,et al.In vitro antifungal susceptibility of Cladophialophora carrionii,an agent of human chromoblastomyeosis[J].Antimicrob Agents Chemother,2013,57(4):1974-1977.
  • 9孙志坚,李若瑜,万喆,王晓红,王端礼.产孢丝状真菌药敏试验检测暗色真菌对九种药物的敏感性[J].中华皮肤科杂志,2004,37(4):197-199. 被引量:10
  • 10Esterre P,Inzan CK,Ramarcel ER,et al.Treatment of chromomycosis with terbinafine:preliminary results of an open pilot study[J].Br J Dermatol,1996,134 (Suppl 46):33-36.

二级参考文献12

  • 1National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi: Proposed Standard M38-P.Pennsylvania, NCCLS, 1998.
  • 2Vanden Bossche H, Warnock DW, Dupont B, et al. Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol,1994, 32 Suppl 1: 189-202.
  • 3Scholer HJ, Polak A. Resistance to systemic antifungal agent. In:Bryan LE, ed, Antimicrobial Drug Resistance. Orlando: Academic,1984. 393-460.
  • 4Jessup C J, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol, 2000, 38: 155-159.
  • 5McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol, 1998, 36: 243-246.
  • 6Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother, 1998, 42: 741-745.
  • 7Caligiorne RB, Resende MA, Melillo PH, et al. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs. Med Mycol, 1999, 37: 405-409.
  • 8章强强,苏逸丹,李莉,王家俊.100株临床分离致病酵母体外药敏试验分析[J].中华皮肤科杂志,2000,33(5):333-335. 被引量:25
  • 9孙志坚,李若瑜,李东明,万喆,王晓红.产孢丝状真菌NCCLS药敏试验方法的应用[J].中华检验医学杂志,2001,24(1):43-44. 被引量:18
  • 10陈宏,温海,徐红,廖万清.伊曲康唑和特比萘芬体外联合药敏试验分析[J].中国皮肤性病学杂志,2003,17(2):99-100. 被引量:15

共引文献13

同被引文献24

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部